Literature DB >> 18802078

Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells.

David C Gondek1, Victor Devries, Elizabeth C Nowak, Li-Fan Lu, Kathryn A Bennett, Zachary A Scott, Randolph J Noelle.   

Abstract

Granzyme B (GZB) has been implicated as an effector mechanism in regulatory T cells (T(reg)) suppression. In a model of T(reg)-dependent graft tolerance, it is shown that GZB- deficient mice are unable to establish long-term tolerance. Moreover, mice overexpressing the inhibitor of GZB, serine protease inhibitor 6, are also resistant to tolerization to alloantigen. Graft survival was shorter in bone marrow-mixed chimeras reconstituted with GZB-deficient T(reg) as compared with wild-type T(reg). Whereas there was no difference in graft survival in mixed chimeras reconstituted with wild-type, perforin-deficient, or Fas ligand-deficient T(reg). Finally, data also show that if alloreactive effectors cannot express FoxP3 and be induced to convert in the presence of competent T(reg), then graft tolerance is lost. Our data are the first in vivo data to implicate GZB expression by T(reg) in sustaining long-lived graft survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802078      PMCID: PMC2572718          DOI: 10.4049/jimmunol.181.7.4752

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

1.  CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection.

Authors:  N D Jones; A Van Maurik; M Hara; B M Spriewald; O Witzke; P J Morris; K J Wood
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

2.  Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.

Authors:  Luke M Williams; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2007-01-14       Impact factor: 25.606

3.  Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL.

Authors:  Dolgor Baatar; Purevdorj Olkhanud; Kenya Sumitomo; Dennis Taub; Ronald Gress; Arya Biragyn
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

4.  Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis.

Authors:  M C Fantini; C Becker; I Tubbe; A Nikolaev; H A Lehr; P Galle; M F Neurath
Journal:  Gut       Date:  2005-09-14       Impact factor: 23.059

5.  Mast cells are essential intermediaries in regulatory T-cell tolerance.

Authors:  Li-Fan Lu; Evan F Lind; David C Gondek; Kathy A Bennett; Michael W Gleeson; Karina Pino-Lagos; Zachary A Scott; Anthony J Coyle; Jennifer L Reed; Jacques Van Snick; Terry B Strom; Xin Xiao Zheng; Randolph J Noelle
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

6.  Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.

Authors:  Sylvaine You; Bertrand Leforban; Corinne Garcia; Jean-François Bach; Jeffrey A Bluestone; Lucienne Chatenoud
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

7.  Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.

Authors:  Jeong M Kim; Jeffrey P Rasmussen; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2006-11-30       Impact factor: 25.606

8.  Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo.

Authors:  Sarah E Weber; Judith Harbertson; Elana Godebu; Guthrie A Mros; Ryan C Padrick; Bryan D Carson; Steven F Ziegler; Linda M Bradley
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

9.  Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.

Authors:  S Read; V Malmström; F Powrie
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

10.  Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

Authors:  T Takahashi; T Tagami; S Yamazaki; T Uede; J Shimizu; N Sakaguchi; T W Mak; S Sakaguchi
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

View more
  47 in total

Review 1.  T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells.

Authors:  Bruce M Hall
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-15       Impact factor: 8.237

2.  Molecular orchestration of differentiation and function of regulatory T cells.

Authors:  Li-Fan Lu; Alexander Rudensky
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

Review 3.  CD46 in innate and adaptive immunity: an update.

Authors:  J Cardone; G Le Friec; C Kemper
Journal:  Clin Exp Immunol       Date:  2011-04-13       Impact factor: 4.330

4.  Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease.

Authors:  Sheng F Cai; Xuefang Cao; Anjum Hassan; Todd A Fehniger; Timothy J Ley
Journal:  Blood       Date:  2009-11-13       Impact factor: 22.113

Review 5.  Pharmacologic targeting of regulatory T cells for solid organ transplantation: current and future prospects.

Authors:  Kassem Safa; Sindhu Chandran; David Wojciechowski
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

Review 6.  T helper 17 cells: discovery, function, and physiological trigger.

Authors:  Miriam Beer Torchinsky; J Magarian Blander
Journal:  Cell Mol Life Sci       Date:  2010-01-07       Impact factor: 9.261

7.  CD46-induced human Treg enhance B-cell responses.

Authors:  Anja Fuchs; John P Atkinson; Veronique Fremeaux-Bacchi; Claudia Kemper
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

8.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

9.  Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression.

Authors:  Timothy I M Tree; Jennifer Lawson; Hannah Edwards; Ania Skowera; Sefina Arif; Bart O Roep; Mark Peakman
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

10.  Induction of granzyme B expression in T-cell receptor/CD28-stimulated human regulatory T cells is suppressed by inhibitors of the PI3K-mTOR pathway.

Authors:  Olga V Efimova; Todd W Kelley
Journal:  BMC Immunol       Date:  2009-11-22       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.